Divis Laboratories Ltd | DIVI - Operating Expenses


Divis Laboratories Ltd reported INR20.17B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Alaunos Therapeutics USD 1.01M 175K Mar/2026
Aurobindo Pharma INR 75.31B 1.94B Mar/2026
Avita Medical AUD 28.02M 1.55M Dec/2025
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Divis Laboratories Ltd INR 20.17B 1.85B Mar/2026
Ionis Pharmaceuticals USD 364M 54M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Lupin INR 52.71B 443.1M Dec/2025
Moderna USD 1.78B 242M Mar/2026
Organon & Co USD 903M 387M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Tectonic Therapeutic USD 21.52M 374K Dec/2025
Tilray USD 237.52M 17.34M Sep/2025
Viatris USD 3.54B 323.9M Mar/2026
Xeris Pharmaceuticals USD 69.03M 1.38M Dec/2025